Teverelix

teverelix · Antev Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Teverelix, covering 2024-07-23 to 2024-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Teverelix Evaluated in Advanced Prostate Cancer [Phase 2]